Colorectal cancer, often known as colon cancer, is the second-leading cause of cancer death in the United States. However, if caught early, the chance of survival might be as high as 90%. The American Cancer Society recently lowered the recommended age for colorectal cancer screening from 50 to 45 to boost the chances of early diagnosis. Combining AI with routine screening earlier in the process has the potential to enhance outcomes for a large number of patients.
Polyps, which are growths on the colon or rectum, are the most common precursors to colorectal cancer. The GI GeniusTM intelligent endoscopy module is distributed by Medtronic, the world’s leading healthcare technology firm, to offer endoscopists a second observer throughout the process. The GI GeniusTM cognitive endoscopy module has been trained with over 13 million meticulously selected photos, covering a wide range of polyp forms and gastroenterologists’ collective knowledge, making it genuinely unique.
In 2019, colorectal cancer was the second most common cause of cancer mortality, trailing only lung cancer. Colorectal cancer risk factors are so frequent that they affect around 1 in every 20 people in the United States. Rectal bleeding, unwanted weight loss, and abdominal pain are all common signs of colorectal cancer and should be taken seriously enough to warrant a visit to the doctor. Colonoscopy screening is the most effective way to detect colorectal cancer early. Routine screenings beginning at age 45, as recently suggested, remain an important component of the puzzle.